Latest Insider Transactions at Vera Therapeutics, Inc. (VERA)
This section provides a real-time view of insider transactions for Vera Therapeutics, Inc. (VERA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2021
|
Patrick G Enright |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Beth C Seidenberg |
BUY
Conversion of derivative security
|
Indirect |
1,343,152
+34.66%
|
-
|
|
May 18
2021
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 17
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Direct |
17,828
+50.0%
|
$213,936
$12.04 P/Share
|